Abstracts S2–S10

@article{Akakura2003AbstractsS,
  title={Abstracts S2–S10},
  author={Koichiro Akakura and Naohide Sato and Shigeo Isaka and Hiroomi Nakatsu and Maya Tanaka and Takeshi Ueda and Icihiro Mori and Toshio Okano and Hirohito Naito and Yuri Sakurayama and Kohei Yamaguchi and Haruo It{\^o}},
  journal={Prostate Cancer and Prostatic Diseases},
  year={2003},
  volume={6},
  pages={S2-S10}
}
Microscopic cancer is seen in the prostate gland already in the fourth decade. However, progress to clinical disease is not seen until decades later, when androgens in serum are declining. On the other hand, androgen ablation is an established treatment of men with prostate cancer (PC), but still 50% of men with prostate cancer will die from the disease. The effect of both testosterone (T) and 5a-dihydrotestosterone is mediated through the androgen receptor (AR), which contains two polymorphic… CONTINUE READING

Similar Papers

Loading similar papers…